150 related articles for article (PubMed ID: 30631150)
21. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
[TBL] [Abstract][Full Text] [Related]
22. High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition.
Bate-Eya LT; den Hartog IJ; van der Ploeg I; Schild L; Koster J; Santo EE; Westerhout EM; Versteeg R; Caron HN; Molenaar JJ; Dolman ME
Oncotarget; 2016 May; 7(19):27946-58. PubMed ID: 27056887
[TBL] [Abstract][Full Text] [Related]
23. MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
Young AI; Law AM; Castillo L; Chong S; Cullen HD; Koehler M; Herzog S; Brummer T; Lee EF; Fairlie WD; Lucas MC; Herrmann D; Allam A; Timpson P; Watkins DN; Millar EK; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR
Breast Cancer Res; 2016 Dec; 18(1):125. PubMed ID: 27931239
[TBL] [Abstract][Full Text] [Related]
24. Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2.
Basu A; Sridharan S
PLoS One; 2017; 12(3):e0173854. PubMed ID: 28301598
[TBL] [Abstract][Full Text] [Related]
25. Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro.
Guo L; Eldridge S; Furniss M; Mussio J; Davis M
Toxicol Appl Pharmacol; 2018 Dec; 360():88-98. PubMed ID: 30268579
[TBL] [Abstract][Full Text] [Related]
26. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
Raha P; Thomas S; Thurn KT; Park J; Munster PN
Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
[TBL] [Abstract][Full Text] [Related]
27. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY
Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383
[TBL] [Abstract][Full Text] [Related]
28. Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
Montraveta A; Xargay-Torrent S; Rosich L; López-Guerra M; Roldán J; Rodríguez V; Lee-Vergés E; de Frías M; Campàs C; Campo E; Roué G; Colomer D
Oncotarget; 2015 Aug; 6(25):21159-72. PubMed ID: 26110568
[TBL] [Abstract][Full Text] [Related]
29. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.
Ding Q; He X; Xia W; Hsu JM; Chen CT; Li LY; Lee DF; Yang JY; Xie X; Liu JC; Hung MC
Cancer Res; 2007 May; 67(10):4564-71. PubMed ID: 17495324
[TBL] [Abstract][Full Text] [Related]
30. Relationship of Mcl-1 isoforms, ratio p21WAF1/cyclin A, and Jun kinase phosphorylation to apoptosis in human breast carcinomas.
Rieber M; Medina JD; Strasberg-Rieber M
Biochem Biophys Res Commun; 2002 Oct; 297(4):943-9. PubMed ID: 12359245
[TBL] [Abstract][Full Text] [Related]
31. MCL-1 is a prognostic indicator and drug target in breast cancer.
Campbell KJ; Dhayade S; Ferrari N; Sims AH; Johnson E; Mason SM; Dickson A; Ryan KM; Kalna G; Edwards J; Tait SWG; Blyth K
Cell Death Dis; 2018 Jan; 9(2):19. PubMed ID: 29339815
[TBL] [Abstract][Full Text] [Related]
32. BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.
Wang CY; Guo ST; Croft A; Yan XG; Jin L; Zhang XD; Jiang CC
Mol Carcinog; 2018 Feb; 57(2):284-294. PubMed ID: 29068469
[TBL] [Abstract][Full Text] [Related]
33. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
Aliabadi HM; Mahdipoor P; Uludağ H
Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477
[TBL] [Abstract][Full Text] [Related]
34. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway.
Wei LH; Kuo ML; Chen CA; Chou CH; Cheng WF; Chang MC; Su JL; Hsieh CY
Oncogene; 2001 Sep; 20(41):5799-809. PubMed ID: 11593385
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Myeloid Cell Leukemia 1 and Activation of Caspases Are Critically Involved in Gallotannin-induced Apoptosis in Prostate Cancer Cells.
Park E; Kwon HY; Jung JH; Jung DB; Jeong A; Cheon J; Kim B; Kim SH
Phytother Res; 2015 Aug; 29(8):1225-36. PubMed ID: 26014377
[TBL] [Abstract][Full Text] [Related]
36. Mcl-1 is regulated by IL-6 and mediates the survival activity of the cytokine in a model of late stage prostate carcinoma.
Cavarretta IT; Neuwirt H; Zaki MH; Steiner H; Hobisch A; Nemeth JA; Culig Z
Adv Exp Med Biol; 2008; 617():547-55. PubMed ID: 18497081
[TBL] [Abstract][Full Text] [Related]
37. Aged black garlic extract inhibits the growth of estrogen receptor-positive breast cancer cells by downregulating MCL-1 expression through the ROS-JNK pathway.
Yang Q; Li F; Jia G; Liu R
PLoS One; 2023; 18(6):e0286454. PubMed ID: 37352173
[TBL] [Abstract][Full Text] [Related]
38. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
[TBL] [Abstract][Full Text] [Related]
39. Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor.
Wu X; Zhang LS; Toombs J; Kuo YC; Piazza JT; Tuladhar R; Barrett Q; Fan CW; Zhang X; Walensky LD; Kool M; Cheng SY; Brekken R; Opferman JT; Green DR; Moldoveanu T; Lum L
Nat Cell Biol; 2017 Oct; 19(10):1226-1236. PubMed ID: 28945232
[TBL] [Abstract][Full Text] [Related]
40. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
Leverson JD; Zhang H; Chen J; Tahir SK; Phillips DC; Xue J; Nimmer P; Jin S; Smith M; Xiao Y; Kovar P; Tanaka A; Bruncko M; Sheppard GS; Wang L; Gierke S; Kategaya L; Anderson DJ; Wong C; Eastham-Anderson J; Ludlam MJ; Sampath D; Fairbrother WJ; Wertz I; Rosenberg SH; Tse C; Elmore SW; Souers AJ
Cell Death Dis; 2015 Jan; 6(1):e1590. PubMed ID: 25590800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
